Covid-19 News and Discussions


Newest COVID-19 shots 54 per cent effective in preventing symptoms: U.S. study​


NEW YORK -
The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work.
The shots became available last year and were designed to better protect against more recent coronavirus variants.
In Thursday's study, the Centers for Disease Control and Prevention(opens in a new tab) looked at 9,000 people who got tested for COVID-19 at CVS and Walgreens pharmacies, checking who tested positive and whether they had gotten a new shot or not.

The 54% finding is similar to what's been reported in other countries, and it's also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of the CDC, the study's lead author.
Studies coming out later this year will assess how effective the shot was at preventing symptoms severe enough to send patients to a doctor's office or hospital, she said.
The CDC recommends the new shots for everyone 6 months and older, but most Americans haven't gotten them. The latest CDC data suggests only about 22% of U.S. adults have gotten the shots, and only 11% of children. The slow uptake meant that it took longer for researchers to gather enough data to assess how well the shots work, Link-Gelles said.
 

You had COVID or the flu: how to know when it’s safe to go back to work​


 

Health Minister says COVID vaccines don't interact with DNA, benefits still outweigh potential risks​


 

Newest COVID-19 shots 54 per cent effective in preventing symptoms: U.S. study​


NEW YORK -
The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work.
The shots became available last year and were designed to better protect against more recent coronavirus variants.
In Thursday's study, the Centers for Disease Control and Prevention(opens in a new tab) looked at 9,000 people who got tested for COVID-19 at CVS and Walgreens pharmacies, checking who tested positive and whether they had gotten a new shot or not.

The 54% finding is similar to what's been reported in other countries, and it's also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of the CDC, the study's lead author.
Studies coming out later this year will assess how effective the shot was at preventing symptoms severe enough to send patients to a doctor's office or hospital, she said.
The CDC recommends the new shots for everyone 6 months and older, but most Americans haven't gotten them. The latest CDC data suggests only about 22% of U.S. adults have gotten the shots, and only 11% of children. The slow uptake meant that it took longer for researchers to gather enough data to assess how well the shots work, Link-Gelles said.

54% is alright but it's a far cry from early Pfizer which was 95% effective. 54% is sort of like a flu shot.
 
54% is alright but not great

New COVID shots 54% effective in preventing symptoms​


 

More Insane LEAKED Government Covid Documents [Covid Origin]​


 

Student test scores slowly rebounding post-COVID​


 

Covid-19 vaccine can help cut the chances of symptomatic infection by half​


 

Nearly $4M grant awarded for long COVID​


 

Boost your immunity with the updated COVID Vaccine​


 

162 - How Covid Changed The Face Of Jehovah's Witnesses (Well, Some Of Them)​


 

$3.9 million award for Albany Medical College to study long-COVID​


 

I was exposed to COVID and tested negative. Should I test again? | COVID Catch-up with Dr. Laz​


 

This Week In Guns-336 – The COVID Conundrum​


 

Users who are viewing this thread

Back
Top